Rankings · Stocks
Best-performing Stocks
Compare investable companies across valuation, growth, quality, income and returns.
Latest complete snapshotAug 31, 2026
Snapshot observation
SharonAI Holdings, Inc. Class A Common Stock has the highest qualifying performance reading. The eligible median is 16.11 across 3399 instruments.
| Rank | Instrument | Classification | Region | Market cap | 1M | YTD | 1Y |
|---|---|---|---|---|---|---|---|
| 11 | PRAXPraxis Precision Medicines Inc | Stock | North America | $9.6B | +11.99% | +16.97% | +657.03% |
| 12 | 0O5CAT & S Austria Technologie & Systemtechnik AG | Stock | Europe | $2.3B | +15.68% | +361.99% | +628.93% |
| 13 | FBRXForte Biosciences Inc | Stock | North America | $1.6B | +0.01% | +182.32% | +599.91% |
| 14 | SLSSellas Life Sciences Group Inc | Stock | North America | $2.7B | +31.97% | +250.40% | +588.02% |
| 15 | LITELumentum Holdings Inc | Stock | North America | $84.2B | +29.10% | +142.82% | +573.90% |
| 16 | IMMXImmix Biopharma Inc | Stock | North America | $1B | +63.04% | +166.54% | +527.93% |
| 17 | ORKAOruka Therapeutics, Inc. | Stock | North America | $6B | -5.55% | +200.73% | +515.88% |
| 18 | WDCWestern Digital Corporation | Stock | North America | $165.7B | -15.67% | +166.90% | +473.43% |
| 19 | MRNAModerna Inc | Stock | North America | $55.1B | +151.71% | +367.92% | +472.81% |
| 20 | SYRESpyre Therapeutics Inc. | Stock | North America | $8B | -8.11% | +175.82% | +447.97% |
Informational only. Rankings are not investment advice, a recommendation, or a prediction of future performance.